Jing Liu - Search Results

Year	Number of Results
2000	2
2001	1
2002	48
2003	48
2004	69
2005	101
2006	128
2007	114
2008	144
2009	210
2010	241
2011	254
2012	323
2013	407
2014	424
2015	462
2016	499
2017	640
2018	724
2019	804
2020	889
2021	1063
2022	1262
2023	579

1

Protein acylation: mechanisms, biological functions and therapeutic targets.

Shang S, Liu J, Hua F. Shang S, et al. Among authors: liu j. Signal Transduct Target Ther. 2022 Dec 29;7(1):396. doi: 10.1038/s41392-022-01245-y. Signal Transduct Target Ther. 2022. PMID: 36577755 Free PMC article. Review.

2

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.

Liu J, Bai W, Zhou T, Xie Y, Yang B, Sun J, Wang Y, Li X, Hou X, Liu Z, Fu D, Yan J, Jiang W, Zhao K, Zhou B, Yuan S, Guo Y, Wang H, Chang A, Gao S, Shi L, Huang C, Yang S, Hao J. Liu J, et al. Gut. 2023 Feb 24:gutjnl-2022-327492. doi: 10.1136/gutjnl-2022-327492. Online ahead of print. Gut. 2023. PMID: 36828627

3

Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.

Xiong Y, Zhong Y, Yim H, Yang X, Park KS, Xie L, Poulikakos PI, Han X, Xiong Y, Chen X, Liu J, Jin J. Xiong Y, et al. Among authors: liu j. J Am Chem Soc. 2022 Dec 14;144(49):22622-22632. doi: 10.1021/jacs.2c09255. Epub 2022 Nov 30. J Am Chem Soc. 2022. PMID: 36448571 Free PMC article.

4

Polystyrene microplastics-induced ROS overproduction disrupts the skeletal muscle regeneration by converting myoblasts into adipocytes.

Shengchen W, Jing L, Yujie Y, Yue W, Shiwen X. Shengchen W, et al. Among authors: jing l. J Hazard Mater. 2021 Sep 5;417:125962. doi: 10.1016/j.jhazmat.2021.125962. Epub 2021 Apr 27. J Hazard Mater. 2021. PMID: 33979708

5

Retraction: Cell membrane based biomimetic nanocomposites for targeted therapy of drug resistant EGFR-mutated lung cancer.

Wu P, Yin D, Liu J, Zhou H, Guo M, Liu J, Liu Y, Wang X, Liu Y, Chen C. Wu P, et al. Among authors: liu j. Nanoscale. 2022 Dec 8;14(47):17802. doi: 10.1039/d2nr90232j. Nanoscale. 2022. PMID: 36444827

6

Solid-state NMR studies of amyloids.

Liu J, Wu XL, Zeng YT, Hu ZH, Lu JX. Liu J, et al. Structure. 2023 Mar 2;31(3):230-243. doi: 10.1016/j.str.2023.01.005. Epub 2023 Feb 6. Structure. 2023. PMID: 36750098 Review.

7

A review: Pathological and molecular biological study on atherosclerosis.

Jing L, Shu-Xu D, Yong-Xin R. Jing L, et al. Clin Chim Acta. 2022 Jun 1;531:217-222. doi: 10.1016/j.cca.2022.04.012. Epub 2022 Apr 14. Clin Chim Acta. 2022. PMID: 35429487 Review.

8

Group 2 Innate Lymphoid Cells Protect Mice from Abdominal Aortic Aneurysm Formation via IL5 and Eosinophils.

Zhang Y, Liu T, Deng Z, Fang W, Zhang X, Zhang S, Wang M, Luo S, Meng Z, Liu J, Sukhova GK, Li D, McKenzie ANJ, Libby P, Shi GP, Guo J. Zhang Y, et al. Among authors: liu j. Adv Sci (Weinh). 2023 Mar;10(7):e2206958. doi: 10.1002/advs.202206958. Epub 2023 Jan 2. Adv Sci (Weinh). 2023. PMID: 36592421 Free PMC article.

9

Insights into the biomarkers of viral encephalitis from clinical patients.

Khushafa T, Jing L, Zhaojun Z, Jiameng S, Haixia Z. Khushafa T, et al. Among authors: jing l. Pathog Dis. 2021 Jan 6;79(1):ftaa073. doi: 10.1093/femspd/ftaa073. Pathog Dis. 2021. PMID: 33238302 Review.

10

Mitochondrial PD-L1 modulates cancer immunotherapy.

Dai X, Liu J, Wei W. Dai X, et al. Among authors: liu j. Cell Res. 2023 May;33(5):335-336. doi: 10.1038/s41422-023-00777-4. Cell Res. 2023. PMID: 36693901 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8,389 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8,389 results

Results by year